Litcius/Paper detail

Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma

Rachael G. Aubin, Emma C. Troisi, Javier Montelongo, Adam N. Alghalith, MacLean P. Nasrallah, Mariarita Santi, Pablo G. Cámara

2022Nature Communications29 citationsDOIOpen Access PDF

Abstract

Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is due to limited knowledge about ependymoma tumorigenic mechanisms. By means of single-nucleus chromatin accessibility and gene expression profiling of posterior fossa primary tumors and distal metastases, we reveal key transcription factors and enhancers associated with the differentiation of ependymoma tumor cells into tumor-derived cell lineages and their transition into a mesenchymal-like state. We identify NFκB, AP-1, and MYC as mediators of this transition, and show that the gene expression profiles of tumor cells and infiltrating microglia are consistent with abundant pro-inflammatory signaling between these populations. In line with these results, both TGF-β1 and TNF-α induce the expression of mesenchymal genes on a patient-derived cell model, and TGF-β1 leads to an invasive phenotype. Altogether, these data suggest that tumor gliosis induced by inflammatory cytokines and oxidative stress underlies the mesenchymal phenotype of posterior fossa ependymoma.

Topics & Concepts

EpendymomaCancer researchBiologyGliosisMesenchymal stem cellPhenotypePathologyEpithelial–mesenchymal transitionMicrogliaMedicineInflammationImmunologyTransition (genetics)GeneGeneticsGlioma Diagnosis and TreatmentImmune cells in cancerNeuroinflammation and Neurodegeneration Mechanisms
Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma | Litcius